A team of South Dakota State University chemistry researchers uncovered how cancer cells utilize a simple sugar residue to disguise themselves from the immune system. What they learned will help scientists develop more effective cancer therapeutics.
"We utilized the lens of organic chemistry to understand how cancer cells evade the immune system," explained assistant chemistry and biochemistry professor Dr. Rachel Willand-Charnley. The project is part of her chemical biology research program, which uses various fields of chemistry to solve biological problems. Willand-Charnley's research has applications in biotechnology and biomedicine.
Willand-Charnley, doctoral students Mathias Anim and Albert Armoo and Susan Grabenstein Roh, a biochemistry major who received her bachelor's degree in May, analyzed what is known as the Sialic acid-Siglec receptor pathway. They examined the pathway in colon and lung cancer cells using CRISPR-Cas9 gene-edited cell lines to determine how the cancer cells evade detection using sugars on their cell surface.
The results are published in the June issue of Glycobiology, a peer-reviewed Oxford Academic research journal. Roh, who at the time was a biochemistry major, is a shared first author on the article. The project was supported by the Willand-Charnley laboratory's startup funding for new faculty members.
Willand-Charnley came to SDSU in 2018 after completing postdoctoral research under the tutelage of renowned chemistry professor Carolyn Bertozzi at the University of California, Berkeley, and then at Stanford University. Her research combines expertise in organic chemistry, glycobiology and cancer immunology.
Cells are literally decorated with sugar residues, known as glycans. Cancers also have a sugar coat. How do sugars, like Sialic acid, allow cancers to participate in 'immune evasion'? The immune system is programmed to identify cellular abnormalities, including deviations in the sugar coat, and mark them for degradation, but the question is why are certain cancer cells not being killed by the immune system?"
Dr. Rachel Willand-Charnley, assistant chemistry and biochemistry professor
The paper focuses on how cancers use simple sugar residues, which she described as a sugary costume, to mimic healthy cells, thereby evading the immune system. "This research will allow scientists to build better therapeutics that cleave off the sugars, essentially removing the cancer cells' sugary costume," Willand-Charnley said. "It will open avenues for more targeted, effective cancer therapeutics related to glycans."
Both doctoral students see the benefits of this unique approach to improving cancer therapeutics. "It was really intriguing to realize that a single genetic modification could actually make cancers resistant to immunotherapy, make them invisible to the immune system," said Anim, who is from Ashiaman, Ghana. He earned his bachelor's and master's degrees in biochemistry at Kwame Nkrumah University of Science and Technology in Kumasi Ashanti, Ghana.
Armoo, who is from Tema, Ghana, said, "For me, it was interesting finding out that a coat of sugar plays a role in resistance to chemotherapeutics. It's not always a drug metabolite, but also the patients' own immune system being able to identify the cancer cells." He began doctoral work at SDSU after earning his undergraduate degree at the University of Bradford in the United Kingdom and a master's degree from the University of Bradford's Institute of Cancer Therapeutics.
Roh, a Mitchell, South Dakota, native, began working on the project as a sophomore. "I wanted to work with genetics, so when Dr. Willand-Charnley talked about cell lines with gene knockouts the first day in my organic chemistry class, that piqued my interest in doing research with her group," Roh said. "I was the first person to sign on (to the project)."
Willand-Charnley said, "Undergraduates (in my lab) are treated like graduate students. My expectation is that they will run their research like a graduate student."
Roh continued, "I found my own papers relating to the topic, read through them and explained why I felt they were relevant and what I learned from them (during the weekly group meetings)." Every three weeks, it was her turn to present her findings to the group-;in a professional fashion. In 2019, Roh received the American Chemical Society award for best undergraduate research poster.
Even though Roh was the only undergraduate student working on the project, she said, "I had a lot of responsibility. I was able to be shared first author on the paper because I put in equal amount of the work-;that's what it took."
In addition to doing research part time during the school year, she also spent two summers working full time on the project. Roh, who is now a graduate research assistant in the Department of Biology and Microbiology, feels prepared for graduate school, thanks to her experiences in Willand-Charnley's lab.
In addition to running successful research programs, Willand-Charnley also focuses on diversity and outreach. "One of my goals as a scientist is to increase diversity in the STEM sciences," Willand-Charnley said. However, "as students traverse academia and get older, we tend to have less diversity, why? One school of thought is that the STEM sciences are seen as intimidating. Thus, how do we fix this?"
Willand-Charley is working on launching an outreach program for kindergarten through fifth graders. "I want to elicit interest in the STEM sciences from a very young age. What better way to garner interest and show that science is fun than hands-on demonstrations with scientists in the classroom?"
Grabenstein, S., et al. (2021) Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway. Glycobiology. doi.org/10.1093/glycob/cwab068.
Read the rest here:
- BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization -... - October 17th, 2021
- Misinformation on stem cell treatments for COVID-19 linked to overhyped science, researchers argue - EurekAlert - October 17th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - BioSpace - October 17th, 2021
- Nic Chapman: my MS battle and the treatment that's given me hope - The Times - October 17th, 2021
- Dream Body Clinic Stem Cell Therapy Stem Cells HGH - October 13th, 2021
- Hematopoietic Stem Cells - October 13th, 2021
- 3D printing: Healthcare insiders' view on the tech - Verdict - October 13th, 2021
- Top 10 Best Stem Cell Supplement Brands - Healthtrends - October 13th, 2021
- Mitochondrial superoxide dismutase overexpression and low oxygen conditioning hormesis improve the performance of irradiated sterile males |... - October 13th, 2021
- The science and practicality of cultured meat The Stute - The Stute - October 11th, 2021
- Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Le - Benzinga - October 11th, 2021
- Want To Support Healthy Bones? It's Time To Get Your Vitamin D In Check - mindbodygreen.com - October 11th, 2021
- Joint : Why Breast Cancer Awareness Matters, and How to Get It Done - marketscreener.com - October 11th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - KY3 - October 7th, 2021
- Fasting boosts stem cells regenerative capacity | MIT ... - October 7th, 2021
- Adventist Review Online | Vaxed, Vexed, or Other? - Adventist Review - October 7th, 2021
- Sickle cell disease patients given hope for the future with first new treatment in 20 years - iNews - October 7th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WCAX - October 7th, 2021
- New Australian-first gene therapy gives Rylee and Saman sight at night and the chance at a new life - ABC News - October 7th, 2021
- Is Stathmin-2 the Next Piece of the ALS Jigsaw Puzzle? - BioSpace - October 7th, 2021
- Ashley Black, Entrepreneur Of The Year For Health And Beauty, To Launch Best-Selling FasciaBlaster System - LatestLY - October 5th, 2021
- 25 Best Body Scrubs and Exfoliators in 2021 - the Trend Spotter - The Trend Spotter - October 5th, 2021
- Potential of exosomes as cell-free therapy | IJN - Dove Medical Press - October 2nd, 2021
- Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting - PRNewswire - October 2nd, 2021
- 12 of the best face serums 2021 - Medical News Today - October 2nd, 2021
- Humanigen Submits All Planned Modules for Potential Conditional Marketing Authorization from the UK's MHRA - Business Wire - October 2nd, 2021
- Envigo Announces Collaboration With Biocytogen to Distribute the B-NDG Triple Immunodeficient and Humanizable Mouse Model - StreetInsider.com - September 29th, 2021
- Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows - Technology Networks - September 29th, 2021
- Sidney author warns against the abuses of technology Saanich News - Saanich News - September 27th, 2021
- Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated... - September 25th, 2021
- Dr. Sean Kelishadi provides stem cell therapy for facial procedures - Digital Journal - September 25th, 2021
- Pipeline of cell and gene therapies holds promise for repairing the Parkinsonian brain - EurekAlert - September 25th, 2021
- National Institutes of Health awards Children - EurekAlert - September 25th, 2021
- Amplitude Healthcare Acquisition : Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc (Form 8-K) -... - September 25th, 2021
- Can you mix and match COVID vaccines or boosters? What scientists and doctors say - CNET - September 22nd, 2021
- All The Reasons Why You Should Add Nutrient-Dense Mushrooms To Your Diet - NDTV Doctor - September 22nd, 2021
- My children know I have a terminal illness talking openly about cancer benefits all of us - iNews - September 22nd, 2021
- Orthopedic Regenerative Surgical Products Market Size to Expand Significantly by the End of 2031 - BioSpace - September 22nd, 2021
- Health tips from Dr. Oz and Dr. Roizen for 9-21-21 - The Commercial Dispatch - September 22nd, 2021
- Prescription Drugs Can Be Affordable and Innovative - Center For American Progress - September 18th, 2021
- The Promise of Regenerative Medicine to Treat Chronic Pain - Mega Doctor News - September 18th, 2021
- Precise CRISPR gene editing can correct the mutation that causes cystic fibrosis in mini-intestines - Massive Science - September 18th, 2021
- Fate Therapeutics Announces Publication of FT538 Preclinical Data Demonstrating Enhanced ... - The Bakersfield Californian - September 18th, 2021
- A New Company With a Wild Mission: Bring Back the Woolly Mammoth - The New York Times - September 14th, 2021
- TreeFrog Therapeutics Secures $75m In Series B Financing To Advance A Pipeline Of Stem Cell-Derived Cell Therapies And Deploy Proprietary C-Stem... - September 14th, 2021
- Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer - pnas.org - September 14th, 2021
- What are the health benefits of nectarines? - Medical News Today - September 10th, 2021
- Time to humanize European health research with an action plan - POLITICO.eu - September 10th, 2021
- Tiny radio tags reveal the lives of Neotropical stingless bees - Massive Science - September 10th, 2021
- Bristol Myers Squibb Research at ESMO 2021 Demonstrates Clinical Benefits of Immunotherapies in Multiple Hard-to-Treat Advanced or Metastatic Cancers... - September 8th, 2021
- Opdivo: Use with Yervoy, Side Effects, Cost, and More - Healthline - September 8th, 2021
- The Deal in Duluth: Catholics here on their own in seeking a religious exemption to being vaccinated - Duluth News Tribune - September 8th, 2021
- Diagnosis and Treatment of Three Primary Malignant Tumors | BCTT - Dove Medical Press - September 8th, 2021
- Jeff Bezos is reportedly funding Altos Labs, a new anti-ageing venture aiming to cheat death - Screen Shot - September 7th, 2021
- Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in... - September 2nd, 2021
- 11 of the best vitamin C serums 2021 - Medical News Today - September 2nd, 2021
- Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination - GOV.UK - September 2nd, 2021
- Japanese scientists have 3D printed a square of lab-grown wagyu beef - The A.V. Club - September 2nd, 2021
- This Company is Producing Bioprinted Fur, Wool & Eyelashes Which Could Make Fur Farms Obsolete - vegconomist - the vegan business magazine -... - September 2nd, 2021
- Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR- - Benzinga - September 1st, 2021
- Operational Highlights and Financial Results for the Year Ended June 30, 2021 - GlobeNewswire - September 1st, 2021
- KNUCKLES Role in Flower Clock; This Tiny Multi-Functional Protein Helps Complete Floral Development Properly at the Right Time - Science Times - September 1st, 2021
- Outlook on the Multiple Myeloma Drugs Global Market to 2026 - by Therapy, Drug Type, End-user, Distribution Channel and Region - Yahoo Finance - August 30th, 2021
- 6 Benefits of Not Eating Meat (or at Least Less of It) - Healthline - August 30th, 2021
- Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical... - August 25th, 2021
- The world's first 3D-printed Wagyu beef is revealed-it's marbling like the real thing - Texasnewstoday.com - August 25th, 2021
- Science-Backed Benefits of Prickly Pear Cactus - Healthline - August 25th, 2021
- AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics | More News | News Channels - PipelineReview.com - August 25th, 2021
- Educating California and the world on the benefits of hydrogen-powered transportation - H2 View - August 25th, 2021
- The Future is Fat: The Startups Looking to Fatten up Vegan Food - vegconomist - the vegan business magazine - August 25th, 2021
- This tech investor believes well soon live to 150. Here are his seven longevity hacks - The Irish Times - August 25th, 2021
- The Best New CBD Skincare Products Of 2021 (So Far) - Forbes - August 25th, 2021
- FDA Approval, Efficacy, Boosters and More: Which COVID Vaccine is Best for You? - NBC Chicago - August 25th, 2021
- Plant Stem Cell Market Technology Research and Global Outlook By Our Experts The Manomet Current - The Manomet Current - August 22nd, 2021
- AAPI's National Blood Donation Drive and Stem Cell Registry Launched, Honoring Fallen Covid Warriors The Indian Panorama - The Indian Panorama - August 22nd, 2021
- Stem Cells Facts and Quiz - WebMD - August 20th, 2021
- Stem cells | healthdirect - August 20th, 2021
- Research Study Published in Functional Foods Highlights Benefits of a Proprietary CBD Formula for Neurological Health - The Free Press Tampa - August 20th, 2021
- Leukemia Stem Cell Transplant: Benefits, Procedure, Side ... - August 20th, 2021
- Fate Therapeutics Announces Positive Interim Clinical Data from its FT596 and FT516 Off-the-shelf, iPSC - GlobeNewswire - August 20th, 2021